In a series of recent updates to federal policy, the landscape of U.S. national policies is set to undergo significant changes. The Justice Department has taken a historic step in U.S. drug policy by initiating a process to reclassify marijuana as a less dangerous drug. Marijuana, long categorized as a Schedule I substance alongside heroin and LSD, is potentially moving to a Schedule III classification, which includes substances like ketamine and anabolic steroids. This reclassification recognizes cannabis’s medical applications and its lower potential for abuse compared to other drugs.
This move was greenlit by Attorney General Merrick Garland and follows a directive from the Health and Human Services Department, which responded to President Joe Biden’s call for a review of the drug’s status. The President has been forthright in correcting what he sees as a “failed approach to marijuana,” stating, “Far too many lives have been upended because of it, and I’m committed to righting those wrongs. You have my word on it.”
This decision is part of a broader trend of decriminalization and acceptance of marijuana, with a growing bipartisan push for drug policy reform. Federal policy has been out of sync with state laws for years, with numerous states legalizing medical and recreational use of marijuana. The rescheduling could lighten the substantial tax burdens on cannabis businesses, facilitate research, and align federal regulation more closely with state laws.
In the arena of technology and national defense, the U.S. Senate AI Working Group has issued a comprehensive policy roadmap for Artificial Intelligence (AI). This bipartisan group, led by Sen. Chuck Schumer and comprising both Democrats and Republicans, provided recommendations on funding, legislation, and further exploration areas. The report follows a series of briefings and forums involving more than 150 experts and aims to guide the development of AI legislation that balances innovation with security and civil liberties.
As the Senate works on translating the AI policy roadmap into concrete legislation, areas like election integrity, workforce training, and AI in healthcare are primed for regulatory development. Notably, the push for AI integration comes with a warning from Sen. Schumer: “If innovation comes at the cost of America’s economic security or civil rights or liberties, it’s going to limit AI’s potential.”
Relevant articles:
– Justice Department formally moves to reclassify marijuana as a less dangerous drug in historic shift, ABC News, 05/16/2024
– US Senate AI Working Group Releases Policy Roadmap, Tech Policy Press, 05/15/2024
Glad you enjoyed above story, be sure to follow TrendyDigests on Microsoft Start.